Palisade Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-62,928
| Closed | -$2M | – | 460 |
|
|
2016
Q3 | $2M | Sell |
62,928
-9,134
| -13% | -$291K | 0.07% | 336 |
|
|
2016
Q2 | $2.34M | Sell |
72,062
-211,837
| -75% | -$6.88M | 0.08% | 310 |
|
|
2016
Q1 | $7.94M | Sell |
283,899
-211,931
| -43% | -$5.93M | 0.26% | 126 |
|
|
2015
Q4 | $17.7M | Sell |
495,830
-144,722
| -23% | -$5.16M | 0.57% | 36 |
|
|
2015
Q3 | $21.2M | Sell |
640,552
-16,189
| -2% | -$535K | 0.62% | 28 |
|
|
2015
Q2 | $27.5M | Sell |
656,741
-48,560
| -7% | -$2.03M | 0.7% | 15 |
|
|
2015
Q1 | $23M | Sell |
705,301
-296,813
| -30% | -$9.67M | 0.58% | 39 |
|
|
2014
Q4 | $31.8M | Buy |
1,002,114
+29,068
| +3% | +$923K | 0.77% | 12 |
|
|
2014
Q3 | $24.1M | Sell |
973,046
-169,492
| -15% | -$4.2M | 0.61% | 26 |
|
|
2014
Q2 | $25.8M | Sell |
1,142,538
-108,226
| -9% | -$2.44M | 0.62% | 23 |
|
|
2014
Q1 | $30.4M | Sell |
1,250,764
-90,085
| -7% | -$2.19M | 0.75% | 14 |
|
|
2013
Q4 | $32.6M | Buy |
1,340,849
+135,198
| +11% | +$3.29M | 0.85% | 9 |
|
|
2013
Q3 | $33.1M | Buy |
1,205,651
+211,517
| +21% | +$5.81M | 0.9% | 6 |
|
|
2013
Q2 | $18M | Buy |
+994,134
| New | +$18M | 0.52% | 45 |
|